154 related articles for article (PubMed ID: 18586498)
1. Progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton.
Nakagawa A; Uno S; Makishima M; Miyachi H; Hashimoto Y
Bioorg Med Chem; 2008 Jul; 16(14):7046-54. PubMed ID: 18586498
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.
Kang FA; Allan G; Guan J; Jain N; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Chen X; Demarest K; Lundeen S; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(4):907-10. PubMed ID: 17169557
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-1H-pyrrole-2-carbonitrile containing tetrahydronaphthalene derivatives as non-steroidal progesterone receptor antagonists.
Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
Bioorg Med Chem Lett; 2010 Aug; 20(16):4816-8. PubMed ID: 20638844
[TBL] [Abstract][Full Text] [Related]
4. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.
Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A
J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484
[TBL] [Abstract][Full Text] [Related]
5. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
[TBL] [Abstract][Full Text] [Related]
6. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
[TBL] [Abstract][Full Text] [Related]
7. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
[TBL] [Abstract][Full Text] [Related]
8. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydroquinoline derivatives as opioid receptor antagonists.
Zhang C; Westaway SM; Speake JD; Bishop MJ; Goetz AS; Carballo LH; Hu M; Epperly AH
Bioorg Med Chem Lett; 2011 Jan; 21(2):670-6. PubMed ID: 21193310
[TBL] [Abstract][Full Text] [Related]
11. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
[TBL] [Abstract][Full Text] [Related]
12. New progesterone receptor antagonists: phosphorus-containing 11beta-aryl-substituted steroids.
Jiang W; Allan G; Fiordeliso JJ; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
Bioorg Med Chem; 2006 Oct; 14(19):6726-32. PubMed ID: 16806946
[TBL] [Abstract][Full Text] [Related]
13. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
Pooley CL; Edwards JP; Goldman ME; Wang MW; Marschke KB; Crombie DL; Jones TK
J Med Chem; 1998 Aug; 41(18):3461-6. PubMed ID: 9719599
[TBL] [Abstract][Full Text] [Related]
14. Novel phosphorus-containing 17beta-side chain mifepristone analogues as progesterone receptor antagonists.
Jiang W; Allan G; Chen X; Fiordeliso JJ; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
Steroids; 2006 Nov; 71(11-12):949-54. PubMed ID: 16934845
[TBL] [Abstract][Full Text] [Related]
15. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
[TBL] [Abstract][Full Text] [Related]
16. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
[TBL] [Abstract][Full Text] [Related]
17. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
[TBL] [Abstract][Full Text] [Related]
18. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
[TBL] [Abstract][Full Text] [Related]
19. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
[TBL] [Abstract][Full Text] [Related]
20. Preparation of leukotriene B(4) inhibitory active 2- and 3-(2-aminothiazol-4-yl)benzo[b]furan derivatives and their growth inhibitory activity on human pancreatic cancer cells.
Kuramoto M; Sakata Y; Terai K; Kawasaki I; Kunitomo J; Ohishi T; Yokomizo T; Takeda S; Tanaka S; Ohishi Y
Org Biomol Chem; 2008 Aug; 6(15):2772-81. PubMed ID: 18633535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
